More specifically its focus is on areas such as kidney stone blasting via stone lasers/lithotripters, ultrasound infection control, guidance of needles or therapeutic instruments under ultrasound control as well as stabilisers and steppers to guide ultrasound procedures during Trans-Perineal Prostate Biopsies, Brachy-Therapy and/or MRI-Fusion Biopsies.


Meditron is now part of the Paragon Care Group

Paragon Care has progressively acquired businesses in the healthcare sector with a focus on those that distribute medical equipment, devices and consumables. Paragon Care Ltd’s (ASX:PGC) acquisition of Meditron, completed on 8 October 2015, represents a consistency with the Company’s strategy to become one of Australia’s leading providers of medical equipment and consumable products to the health and aged care sector throughout Australia and New Zealand.

The addition of the Meditron businesses will enhance the Company’s strong organic growth profile, while lowering overall risk through product and geographic diversification.